Publication: Vesiculobullous diseases in relation to lupus erythematosus
Issued Date
2019-01-01
Resource Type
ISSN
11787015
Other identifier(s)
2-s2.0-85073369282
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical, Cosmetic and Investigational Dermatology. Vol.12, (2019), 653-667
Suggested Citation
Suthinee Rutnin, Kumutnart Chanprapaph Vesiculobullous diseases in relation to lupus erythematosus. Clinical, Cosmetic and Investigational Dermatology. Vol.12, (2019), 653-667. doi:10.2147/CCID.S220906 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/52063
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Vesiculobullous diseases in relation to lupus erythematosus
Author(s)
Other Contributor(s)
Abstract
© 2019 Rutnin and Chanprapaph. Vesiculobullous lesions in lupus erythematosus (LE) are a rare cutaneous manifestation of cutaneous and/or systemic LE with variable presentation. While the minor forms of LE-associated vesiculobullous disease may cause disfigurement and discomfort, the severe forms can present with hyperacute reaction and life-threatening consequences. Specific LE and aspecific cutaneous LE are defined by the presence or absence of interface change on histopathology that can be applied to vesiculobullous diseases in relation to LE. However, the diagnosis of LE-associated vesiculobullous diseases remains difficult, due to the poorly defined nosology and the similarities in clinical and immunohistopathological features among them. Herein, we thoroughly review the topic of vesiculobullous skin disorders that can be encountered in LE patients and organize them into four groups: LE-specific and aspecific vesiculobullous diseases, LE-related autoimmune bullous diseases, and LE in association to non-autoimmune conditions. We sought to provide an updated overview highlighting the pathogenesis, clinical, histological, and immunopathological features, laboratory findings, and treatments and prognosis among vesiculobullous conditions in LE.